Each year, Partnership for Safe Medicines Vice President Dr. Bryan Liang hosts a health policy conference in San Diego.

We’re happy to report that all seats have been filled for his March 26, 2010 conference, “Pharmaceutical Crime: Investigating and Prosecuting Drug Diversion and Counterfeiting,” sponsored by the Institute of Health Law Studies at the California Western School of Law.

The response is important to note as it signals that more individuals in the private and public sector are committed to working together to mitigate the growing threat of counterfeit drugs.

This year’s conference will bring together stakeholders with experience in investigating and prosecuting pharmaceutical diversion and counterfeiting. Attendees will explore the legal infrastructure necessary to allow prosecutors to do their work, the practical strategies on effective prosecution, the unique efforts required to investigate these crimes, and the role of the private sector.

Remember, if you’re unable to join Dr. Liang in San Diego, the proceedings from the event will be published in a special issue of the Journal of Biolaw & Business.